Cargando…
Association of TP53 Alteration with Tissue Specificity and Patient Outcome of IDH1-Mutant Glioma
Since the initial discovery of recurrent isocitrate dehydrogenase 1 (IDH1) mutations at Arg132 in glioma, IDH1 hotspot mutations have been identified in cholangiocarcinoma, chondrosarcoma, leukemia, and various other types of cancer of sporadic incidence. Studies in glioma and leukemia have helped p...
Autores principales: | Murnyak, Balazs, Huang, L. Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394030/ https://www.ncbi.nlm.nih.gov/pubmed/34440884 http://dx.doi.org/10.3390/cells10082116 |
Ejemplares similares
-
Immunohistochemical correlates of TP53 somatic mutations in cancer
por: Murnyák, Balázs, et al.
Publicado: (2016) -
Remote intracranial recurrence of IDH mutant gliomas is associated with TP53 mutations and an 8q gain
por: Nakae, Shunsuke, et al.
Publicado: (2017) -
Computational Analysis of IDH1, IDH2, and
TP53 Mutations in Low-Grade Gliomas Including
Oligodendrogliomas and Astrocytomas
por: Bendahou, Mohammed Amine, et al.
Publicado: (2020) -
Single-nucleus transcriptomics of IDH1- and TP53-mutant glioma stem cells displays diversified commitment on invasive cancer progenitors
por: Gulaia, Valeriia, et al.
Publicado: (2022) -
Therapies for IDH-Mutant Gliomas
por: Alshiekh Nasany, Ruham, et al.
Publicado: (2023)